Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | |
|---|---|---|
| Total revenue | ||
| Cost of revenue | ||
| Gross profit | ||
| Operating expense | 61.99%3.64M | 2.25M |
| Selling and administrative expenses | 126.34%1.57M | --692.89K |
| -General and administrative expense | 126.34%1.57M | --692.89K |
| Depreciation amortization depletion | --17.31K | ---- |
| -Depreciation and amortization | --17.31K | ---- |
| Other operating expenses | 32.20%2.06M | --1.55M |
| Operating profit | -61.99%-3.64M | -2.25M |
| Net non-operating interest income (expenses) | 2,947.91%424.17K | -14.89K |
| Non-operating interest income | 4,524.60%424.17K | --9.17K |
| Non-operating interest expense | ---- | --24.07K |
| Other net income (expenses) | ||
| Income before tax | -42.18%-3.22M | -2.26M |
| Income tax | 0 | 0 |
| Earnings from equity interest net of tax | ||
| Net income | -42.18%-3.22M | -2.26M |
| Net income continuous operations | -42.18%-3.22M | ---2.26M |
| Noncontrolling interests | ||
| Net income attributable to the company | -42.18%-3.22M | -2.26M |
| Preferred stock dividends | ||
| Other under preferred stock dividend | ||
| Net income attributable to common stockholders | -42.18%-3.22M | -2.26M |
| Diluted earnings per share | ||
| Basic earnings per share | ||
| Dividend per share | ||
| Accounting Standards | US-GAAP | US-GAAP |